文献速递睡眠呼吸障碍

CPAP对老年OSA患者嗜睡、认知、情绪和生活质量改善的疗效:随机对照试验的系统评价和Meta分析

Efficacy of CPAP for Improvements in Sleepiness, Cognition, Mood, and Quality of Life in Elderly Patients With OSA: Systematic Review and Meta-analysis of Randomized Controlled Trials.
PubMed 文献 · Chest · 2020-04-11

该系统评价和Meta分析纳入4项随机对照试验共680例老年OSA患者,评估CPAP与常规护理或假CPAP相比对嗜睡、健康相关生活质量、情绪和认知的影响。结果显示CPAP可改善嗜睡(ESS评分降低2.62分)、多个生活质量领域和抑郁情绪,神经认知测试有轻微改善,但证据质量低至极低。

要点

  • CPAP可改善老年OSA患者的嗜睡,ESS评分平均降低2.62分。
  • CPAP改善生活质量多个领域(嗜睡、日间症状、夜间症状、情绪、社交互动)及抑郁情绪。
  • 证据质量低至极低,因偏倚风险较高,不能支持所有老年患者均获益。

核心结论

  • CPAP治疗在老年OSA患者的嗜睡、健康相关生活质量和情绪方面有重要临床改善,神经认知测试有轻微改善,但偏倚风险和质量证据问题不支持所有患者均获益。

研究设计与样本

  • 系统评价和Meta分析,纳入4项随机对照试验,共680例老年(≥65岁)OSA患者,比较CPAP与常规护理或假CPAP。

主要发现

  • CPAP还改善了医院焦虑抑郁量表的抑郁领域,神经认知测试有轻微改善的报告。
  • 所有结局的证据质量评为低至极低。

临床怎么用

  • 对于老年OSA患者,CPAP可考虑用于改善嗜睡、生活质量和情绪,但需结合个体情况和证据质量低的特点权衡获益。

局限性

  • 纳入试验的偏倚风险在实施和检测偏倚方面较高。
  • 所有结局的证据质量评为低至极低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: OSA is found commonly in the elderly population (≥65 years old), and CPAP improves sleepiness and health-related quality of life (HRQoL) in the middle-aged population; however, data about its efficacy in elderly patients are unclear. The purpose of this study was to evaluate the efficacy of CPAP for sleepiness, HRQoL, mood, and cognition in elderly patients with OSA. RESEARCH QUESTION: In elderly patients (≥65 years old) with OSA, is CPAP, compared with usual care or sham CPAP, effective at improving sleepiness, HRQoL, mood, and neurocognitive function? STUDY DESIGN AND METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials that included trials performed in elderly patients with OSA. As an intervention, we compared CPAP vs a control group. Two independent reviewers explored several databases; risk of bias (RoB) was evaluated with the Cochrane tool. Changes in sleepiness (Epworth Sleepiness Scale), HRQoL (Quebec Sleep Questionnaire), mood (Hospital Anxiety-Depression Scale), and neurocognitive tests after treatment were the outcomes. The meta-analysis was conducted according to the DerSimonian-Laird method, and the quality of evidence was rated according to the GRADE guidelines. RESULTS: A total of 4 randomized controlled trials (680 participants) were included. RoB was high for performance and detection bias. CPAP was associated with a 2.62-point improvement in the Epworth Sleepiness Scale (1.93 to 3.30; I2 = 52%). All domains of the Quebec Sleep Questionnaire were improved: hypersomnolence, 0.67 points (0.31 to 1.03; I2 = 75%); diurnal symptoms, -0.71 points (-0.98 to -0.44; I2 = 58%); nocturnal symptoms, 1.09 points (0.9 to 1.27; I2 = 9%); emotions, 0.45 points (0.30 to 0.61; I2 = 11%); and social interaction, 0.55 points (0.1 to 0.99; I2 = 82%). CPAP also improved the Hospital Anxiety-Depression Scale depression domain, and there were reports of a slight improvement in neurocognitive tests. The quality of evidence was low and very low for all outcomes. INTERPRETATION: Although CPAP therapy reportedly results in important clinical differences in sleepiness, HRQoL, and mood and a slight improvement in neurocognitive tests, concerns regarding the RoB and quality of the evidence do not support the benefit in all patients. TRIAL REGISTER: PROSPERO ID CRD42019146947.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Labarca G, Saavedra D, Dreyse J, et al. Efficacy of CPAP for Improvements in Sleepiness, Cognition, Mood, and Quality of Life in Elderly Patients With OSA: Systematic Review and Meta-analysis of Randomized Controlled Trials. Chest. 2020. PMID: 32289311. doi:10.1016/j.chest.2020.03.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。